The Global Interventional Cardiovascular Device Market size is projected to reach USD XX billion by 2028. This growth can be attributed to the rising prevalence of cardiovascular diseases globally, due to which the number of patients undergoing interventional procedures for treatment has increased. The US and China are expected to account for a major share in the global interventional cardiology device market while outgrowing other regions in terms of revenue generation during 2021-2028.
A cardiac device is a medical device used to image, diagnose or treat conditions of the heart. Interventional cardiology devices are those tools that physicians use for performing catheterization with balloon angioplasty which opens blocked coronary arteries and provide relief from chest pain caused by clogged blood vessels in the heart muscle due to atherosclerosis. They can be broadly classified into imaging systems, balloons, stents, and other types of interventional cardiovascular devices. The interventional cardiology devices are mainly divided into diagnostic and therapeutic categories. Diagnostic catheters have the ability to identify any blockages in blood flow by injecting contrast dye, while therapeutic catheters provide treatments for narrowing arteries with balloons or stents.
On the basis of Type, the global interventional cardiovascular device market is segmented into Imaging Systems, Catheter, PTCA Balloon, Stent, and Other.
Imaging Systems type of interventional cardiovascular device is an imaging tool that primarily provides cardiac mapping and diagnostic through the use of a catheter. It is a device that helps in the visualization of blood vessels and the heart. It can be used to see any blockages that may exist prior to performing treatment procedures. Examples include Angiography, Duplex Ultrasound Imaging System, Fluoroscopy system, Magnetic Resonance Imaging (MRI) system.
A catheter is a thin, flexible device inserted into the body through natural orifices, incisions in the skin, and other access points. Catheters are used to provide fluid samples for testing as well as introducing drugs or fluids directly into tissues during medical procedures such as Interventional Cardiology. Examples include Ablative Cooling Catheter System, Aortic Balloon Pacing Systems, Bioptome Endovascular Grafts (BEG), Carotid Stents, Intra-Arterial Thrombolysis Systems.
A balloon is threaded through a catheter, inflated to compress plaque in the artery and allow blood flow. The balloon is inserted into a narrow tube called a catheter that has been threaded through an incision near the groin area all the way to the clogged artery in the heart. The balloon is then inflated inside the narrowed artery, and blood flow returns through a second tube called an endotracheal catheter that was inserted into your windpipe earlier. When the procedure has finished, both tubes (the PTCA Balloon and Endotracheal Catheter) are removed from the body.. This is also called angioplasty or percutaneous transluminal coronary angioplasty (PTCA). PTCA balloons come in different shapes, sizes, lengths, materials of construction, and coatings for various body applications.
A stent is a small, flexible tube made of metal mesh that's inserted into the body near an obstruction. It helps keep an artery open or supports other structures like the urethra to allow normal flow through it. It can be used for many conditions including angina (chest pain), heart attack, strokes, and narrowing from atherosclerosis in arteries throughout the body. The term "stent" comes from its main function: strengthening. Stents are typically placed by a catheter which guides them to their desired location within the blood vessel where they expand due to the pressure of being inside your vessels. They stay in place permanently when correctly positioned but others may need removal after some time if no longer needed. Stents come with many different materials and coatings to help prevent clotting.
On the basis of Application, the global interventional cardiovascular device market is segmented into Hospital, Clinic.
In the past decade, hospitals have been investing in new technologies to improve patient outcomes and reduce costs. One of these is by using interventional cardiovascular devices. These devices are used for diagnosis and treatment during a heart attack or other conditions such as clogged arteries. Hospitals use interventional cardiovascular devices to access the heart and other parts of the circulatory system. It is a medical procedure that involves performing catheter-based interventions on blood vessels, which are used for the diagnosis or treatment of various conditions in these areas.
The use of interventional cardiovascular devices in clinics is aimed at treating or preventing a number of conditions including coronary artery disease, clogged arteries, and blocked veins. Interventional cardiology procedures can often be performed quickly with minimal downtime. In addition to catheters for the heart and vascular system, other types of equipment may include imaging systems (e.g., echo-cardiographs), guidewires used during angioplasty, stents that are implanted within an arterial wall to help expand it after narrowing occurs following a procedure such as a balloon dilatation or PTCA (percutaneous transluminal coronary angioplasty).
On the basis of Region, the global interventional cardiovascular device market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. In North America, the United States dominates in this region. The other countries in this region are Canada and Mexico. Furthermore, in Latin America Brazil is one of the leading markets for interventional cardiovascular devices followed by Argentina. In Europe Germany leads with approximately 40% shares. Countries like France and Italy are also significant players here while Russia has a huge potential to be tapped if it starts investing in research & development related to these device technologies significantly more than before which could result in outflow flow of investments from other regions where Russian companies have traditionally invested heavily so far such as China or India for example. The Asian Region is one of the fastest-growing markets for these devices. In this region, China and India are the major players as they account for a 55% share of all cardiovascular device sales in the Asia Pacific Region while Japan comes third with 15%. Middle East & Africa holds an important position with a growing number of cardiovascular diseases coupled with strong economic growth in this region.
The factors such as the incidences of heart diseases, the increasing number of deaths due to cardiovascular disease, and the introduction and development of new technologies are propelling the growth in the global interventional cardiovascular device market. Moreover, technological advancements have facilitated diagnosis procedures which have led to a rise in demand for interventional cardiology devices globally. Further, increased healthcare expenditure across both developed and developing countries are also acting as a driving force for this market's growth. Moreover, recent studies reveal that there is an increasing trend towards minimally invasive cardiac surgery like percutaneous coronary intervention (PCI). Increasing awareness among patients about treatment options available through PCI or PTCA procedure will drive this segment's revenue over the forecast period owing to its less-invasive nature and reduced risk of mortality.
Up Market Research published a new report titled “Interventional Cardiovascular Device Sales Market research report which is segmented by Types (Imaging System, Catheter, PTCA Balloon, Stent, PTCA Guidewire, Other), By Applications (Hospital, Clinic), By Players/Companies GE Healthcare, Boston Scientific, Philips, Volcano Therapeutics, Argon Medical, Spectranetics, Angio Dynamics, AccessClosure, Merit Medical Systems, B. Braun, C. R. Bard, Marine Polymer Technologies, Cordis”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Attributes | Report Details |
Report Title | Interventional Cardiovascular Device Sales Market Research Report |
By Type | Imaging System, Catheter, PTCA Balloon, Stent, PTCA Guidewire, Other |
By Application | Hospital, Clinic |
By Companies | GE Healthcare, Boston Scientific, Philips, Volcano Therapeutics, Argon Medical, Spectranetics, Angio Dynamics, AccessClosure, Merit Medical Systems, B. Braun, C. R. Bard, Marine Polymer Technologies, Cordis |
Regions Covered | North America, Europe, APAC, Latin America, MEA |
Base Year | 2020 |
Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
Forecast Year | 2028 |
Number of Pages | 240 |
Number of Tables & Figures | 168 |
Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Type Imaging System, Catheter, PTCA Balloon, Stent, PTCA Guidewire, Other and By Application Hospital, Clinic.
Some of the companies that are profiled in this report are:
Interventional Cardiovascular Device Sales Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Interventional Cardiovascular Device Sales Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Interventional Cardiovascular Device Sales Market Report:
Some other reports from this category!